PT  - JOURNAL ARTICLE
AU  - Lorenzo-Leal, Ana C.
AU  - Vimalanathan, Selvarani
AU  - Bach, Horacio
TI  - Adherence of SARS-CoV-2 delta variant to surgical mask and N95 respirators
AID  - 10.1101/2022.01.05.22268808
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.01.05.22268808
4099  - http://medrxiv.org/content/early/2022/01/06/2022.01.05.22268808.short
4100  - http://medrxiv.org/content/early/2022/01/06/2022.01.05.22268808.full
AB  - The use of facial protection, including masks and respirators, has been adopted globally due to the COVID-19 pandemic. These products have been demonstrated to be effective in reducing the transmission of the virus. To determine whether or not the virus adheres to masks and respirators, we dissected four respirators and one surgical mask into layers. These individual layers were contaminated with the SARS-CoV-2 delta variant, and its release by vortexing was performed. Samples were used to infect Vero cells, and a plaque assay was used to determine to evaluate the adherence of the virus. Results showed that a cumulative log reduction of the layers reduced the load of the virus six-folds. Our study confirms the effectiveness of facial protection in reducing the transmission and or infection of the virus.Competing Interest StatementThe authors have declared no competing interest.Funding StatementCanadian Institutes of Health Research (CIHR) grant Canadian 2019 Novel Coronavirus (COVID-19) Rapid Research Funding Opportunity Therapeutics to H.B (No. OV3- 170627)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present work are contained in the manuscript